skip to content
A pharmacoeconomic review of cholinesterase inhibitor drugs for Alzheimer's disease Preview this item
ClosePreview this item
Checking...

A pharmacoeconomic review of cholinesterase inhibitor drugs for Alzheimer's disease

Author: Kathryn Coyle; Douglas Coyle
Publisher: [Ottawa, Ontario] : [University of Ottawa], Ottawa, Ontario : Canadian Electronic Library, 2013. 2016.
Edition/Format:  eBook : Document : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Kathryn Coyle; Douglas Coyle
OCLC Number: 946888785
Notes: "November 2013."
Description: 1 online resource (38 pages) : tables
Responsibility: Kathryn Coyle, Doug Coyle.
More information:

Reviews

User-contributed reviews

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/946888785<\/a>> # A pharmacoeconomic review of cholinesterase inhibitor drugs for Alzheimer\'s disease<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Book<\/a>, schema:CreativeWork<\/a>, schema:MediaObject<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"946888785<\/span>\" ;\u00A0\u00A0\u00A0\nlibrary:placeOfPublication<\/a> <http:\/\/id.loc.gov\/vocabulary\/countries\/onc<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/alzheimer_s_disease_chemotherapy<\/a>> ; # Alzheimer\'s disease--Chemotherapy<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/drugs_cost_effectiveness<\/a>> ; # Drugs--Cost effectiveness<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/pharmaceutical_research_canada<\/a>> ; # Pharmaceutical research--Canada<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Place\/canada<\/a>> ; # Canada<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/dewey.info\/class\/616.831\/e20\/<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/drugs_canada_cost_effectiveness<\/a>> ; # Drugs--Canada--Cost effectiveness<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/cholinesterase_inhibitors_therapeutic_use_effectiveness<\/a>> ; # Cholinesterase inhibitors--Therapeutic use--Effectiveness<\/span>\n\u00A0\u00A0\u00A0\nschema:author<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Person\/coyle_douglas<\/a>> ; # Douglas Coyle<\/span>\n\u00A0\u00A0\u00A0\nschema:author<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Person\/coyle_kathryn<\/a>> ; # Kathryn Coyle<\/span>\n\u00A0\u00A0\u00A0\nschema:bookFormat<\/a> schema:EBook<\/a> ;\u00A0\u00A0\u00A0\nschema:copyrightYear<\/a> \"2013<\/span>\" ;\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2016<\/span>\" ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/2941179997<\/a>> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Electronic books<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:inLanguage<\/a> \"en<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"A pharmacoeconomic review of cholinesterase inhibitor drugs for Alzheimer\'s disease<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"946888785<\/span>\" ;\u00A0\u00A0\u00A0\nschema:url<\/a> <https:\/\/www.deslibris.ca\/ID\/10049083<\/a>> ;\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/books.scholarsportal.info\/viewdoc.html?id=\/ebooks\/ebooks3\/gibson_chrc\/2016-04-25\/1\/10049083<\/a>> ;\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/site.ebrary.com\/id\/11188624<\/a>> ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/946888785<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/dewey.info\/class\/616.831\/e20\/<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Person\/coyle_douglas<\/a>> # Douglas Coyle<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:familyName<\/a> \"Coyle<\/span>\" ;\u00A0\u00A0\u00A0\nschema:givenName<\/a> \"Douglas<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Douglas Coyle<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Person\/coyle_kathryn<\/a>> # Kathryn Coyle<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:familyName<\/a> \"Coyle<\/span>\" ;\u00A0\u00A0\u00A0\nschema:givenName<\/a> \"Kathryn<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Kathryn Coyle<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Place\/canada<\/a>> # Canada<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Canada<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/alzheimer_s_disease_chemotherapy<\/a>> # Alzheimer\'s disease--Chemotherapy<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Alzheimer\'s disease--Chemotherapy<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/cholinesterase_inhibitors_therapeutic_use_effectiveness<\/a>> # Cholinesterase inhibitors--Therapeutic use--Effectiveness<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Cholinesterase inhibitors--Therapeutic use--Effectiveness<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/drugs_canada_cost_effectiveness<\/a>> # Drugs--Canada--Cost effectiveness<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Drugs--Canada--Cost effectiveness<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/drugs_cost_effectiveness<\/a>> # Drugs--Cost effectiveness<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Drugs--Cost effectiveness<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/2941179997#Topic\/pharmaceutical_research_canada<\/a>> # Pharmaceutical research--Canada<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Pharmaceutical research--Canada<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/vocabulary\/countries\/onc<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\ndcterms:identifier<\/a> \"onc<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/946888785<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/946888785<\/a>> ; # A pharmacoeconomic review of cholinesterase inhibitor drugs for Alzheimer\'s disease<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2020-04-27<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/WorldCat<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Content-negotiable representations<\/p>\n